145 related articles for article (PubMed ID: 1375115)
1. Pharmacokinetics of subcutaneous recombinant human granulocyte colony-stimulating factor in children.
Stute N; Santana VM; Rodman JH; Schell MJ; Ihle JN; Evans WE
Blood; 1992 Jun; 79(11):2849-54. PubMed ID: 1375115
[TBL] [Abstract][Full Text] [Related]
2. Disposition of recombinant human granulocyte colony-stimulating factor in children with severe chronic neutropenia.
Kearns CM; Wang WC; Stute N; Ihle JN; Evans WE
J Pediatr; 1993 Sep; 123(3):471-9. PubMed ID: 7689097
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of intravenous recombinant human granulocyte colony-stimulating factor (rhG-CSF) in children receiving myelosuppressive cancer chemotherapy: clearance increases in relation to absolute neutrophil count with repeated dosing.
Sturgill MG; Huhn RD; Drachtman RA; Ettinger AG; Ettinger LJ
Am J Hematol; 1997 Feb; 54(2):124-30. PubMed ID: 9034286
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte-colony stimulating factor and multiple cycles of strongly myelosuppressive alkylator-based combination chemotherapy in children with neuroblastoma.
Kushner BH; Heller G; Kramer K; Cheung NK
Cancer; 2000 Nov; 89(10):2122-30. PubMed ID: 11066054
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of recombinant human granulocyte-macrophage colony-stimulating factor in children after intravenous and subcutaneous administration.
Stute N; Furman WL; Schell M; Evans WE
J Pharm Sci; 1995 Jul; 84(7):824-8. PubMed ID: 7562431
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of delayed granulocyte colony-stimulating factor after full dose CHOP therapy in non-Hodgkin's lymphoma: a pilot study for a leukocyte count oriented regimen.
Sawada KI; Sato N; Kohno M; Hannda H; Yasukouchi T; Tanngo M; Hirayama A; Koike T
Leuk Lymphoma; 1995 Dec; 20(1-2):103-9. PubMed ID: 8750630
[TBL] [Abstract][Full Text] [Related]
7. Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.
Yoshida O; Kakehi Y; Arai Y; Tomoyoshi T; Okada Y; Matsuda T; Mikami O; Fukuyama T; Hida S; Okabe T
Int J Urol; 1995 Nov; 2(5):316-21. PubMed ID: 8749950
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Single and multiple dosing studies.
Tanaka H; Kaneko T
Drug Metab Dispos; 1991; 19(1):200-4. PubMed ID: 1708329
[TBL] [Abstract][Full Text] [Related]
9. Recombinant human thrombopoietin in combination with granulocyte colony-stimulating factor enhances mobilization of peripheral blood progenitor cells, increases peripheral blood platelet concentration, and accelerates hematopoietic recovery following high-dose chemotherapy.
Somlo G; Sniecinski I; ter Veer A; Longmate J; Knutson G; Vuk-Pavlovic S; Bhatia R; Chow W; Leong L; Morgan R; Margolin K; Raschko J; Shibata S; Tetef M; Yen Y; Forman S; Jones D; Ashby M; Fyfe G; Hellmann S; Doroshow JH
Blood; 1999 May; 93(9):2798-806. PubMed ID: 10216073
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte-macrophage colony-stimulating factor in neutropenic children with malignancies.
Lydaki E; Bolonaki E; Stiakaki E; Dimitriou H; Kalmantis T; Kalmanti M
Pediatr Hematol Oncol; 1995; 12(6):551-8. PubMed ID: 8589000
[TBL] [Abstract][Full Text] [Related]
11. [Effects of recombinant human granulocyte colony-stimulating factor on superoxide production by neutrophil in cancer patients receiving chemotherapy].
Yoshida M; Oshi M; Aso Y; Yanagisawa R; Kishi H; Ishida Y
Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1262-8. PubMed ID: 7689123
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of recombinant human granulocyte colony-stimulating factor and recombinant human granulocyte macrophage colony-stimulating factor in permitting the administration of higher doses of cyclophosphamide in a doxorubicin-cyclophosphamide combination. An NSABP pilot study in patients with metastatic or high-risk primary breast cancer. National Surgical Adjuvant Breast and Bowel Project.
Mamounas EP; Anderson S; Wickerham DL; Clark R; Stoller R; Hamm JT; Stewart JA; Bear HD; Glass AG; Bornstein R
Am J Clin Oncol; 1994 Oct; 17(5):374-81; discussion 382. PubMed ID: 7522393
[TBL] [Abstract][Full Text] [Related]
13. [Clinical effect of recombinant human G-CSF on neutropenia induced by chemotherapy for non-Hodgkin's lymphoma].
Oyama A; Ota K; Asano S; Takaku F; Miyazaki T; Uzuka Y; Omine M; Furusawa S; Hirashima K; Sanpi K
Nihon Gan Chiryo Gakkai Shi; 1990 Aug; 25(8):1619-34. PubMed ID: 1700040
[TBL] [Abstract][Full Text] [Related]
14. Use of recombinant human granulocyte colony-stimulating factor to increase chemotherapy dose-intensity: a randomized trial in very high-risk childhood acute lymphoblastic leukemia.
Michel G; Landman-Parker J; Auclerc MF; Mathey C; Leblanc T; Legall E; Bordigoni P; Lamagnere JP; Demeocq F; Perel Y; Auvrignon A; Berthou C; Bauduer F; Pautard B; Schneider P; Schaison G; Leverger G; Baruchel A
J Clin Oncol; 2000 Apr; 18(7):1517-24. PubMed ID: 10735900
[TBL] [Abstract][Full Text] [Related]
15. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
[TBL] [Abstract][Full Text] [Related]
16. Albugranin, a recombinant human granulocyte colony stimulating factor (G-CSF) genetically fused to recombinant human albumin induces prolonged myelopoietic effects in mice and monkeys.
Halpern W; Riccobene TA; Agostini H; Baker K; Stolow D; Gu ML; Hirsch J; Mahoney A; Carrell J; Boyd E; Grzegorzewski KJ
Pharm Res; 2002 Nov; 19(11):1720-9. PubMed ID: 12458679
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte colony-stimulating factor serum and urine concentrations in neutropenic neonates before and after intravenous administration of recombinant granulocyte colony-stimulating factor.
Calhoun DA; Lunøe M; Du Y; Hutson AD; Veerman M; Christensen RD
Pediatrics; 2000 Feb; 105(2):392-7. PubMed ID: 10654961
[TBL] [Abstract][Full Text] [Related]
18. [Clinical significance of recombinant human granulocyte colony-stimulating factor (rG-CSF) in the chemotherapy of patients with malignant lymphoma].
Kuzuyama Y; Sonoda Y; Okuda T; Takashima T; Misawa S; Kashima K; Nakagawa H; Fujii H; Abe T
Rinsho Ketsueki; 1992 Dec; 33(12):1789-96. PubMed ID: 1282572
[TBL] [Abstract][Full Text] [Related]
19. Results of a phase I/II trial of recombinant human granulocyte-macrophage colony-stimulating factor in very low birthweight neonates: significant induction of circulatory neutrophils, monocytes, platelets, and bone marrow neutrophils.
Cairo MS; Christensen R; Sender LS; Ellis R; Rosenthal J; van de Ven C; Worcester C; Agosti JM
Blood; 1995 Oct; 86(7):2509-15. PubMed ID: 7670096
[TBL] [Abstract][Full Text] [Related]
20. G-CSF serum pharmacokinetics during peripheral blood progenitor cell mobilization: neutrophil count-adjusted dosage might potentially improve mobilization and be more cost-effective.
Faulkner LB; Tucci F; Tamburini A; Tintori V; Lippi AA; Bambi F; Malentacca F; Azzari C; Gelli AM; Genovese F; Bernini G
Bone Marrow Transplant; 1998 Jun; 21(11):1091-5. PubMed ID: 9645570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
